The AVA 1 fund has invested €3.5 million in Synboli, a French startup that innovates polymer discovery through AI technology, aiming to enhance sustainable materials development.
Target Information
We are pleased to announce the inclusion of Synboli in the AVA 1 fund portfolio, following its successful €3.5 million Seed funding round led by Aquiti in collaboration with Wind Capital. Synboli, a company spun out from CNRS and the University of Bordeaux, is set to revolutionize the discovery of new polymers through its innovative synthesis technology and artificial intelligence.
This approach enables the rapid development of customized materials that are biodegradable, bio-based, and free from toxic substances. The recent funding will facilitate the establishment of a new laboratory in Bordeaux, enhance its technology platform, and contribute to building the world's largest polymer database.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The polymer industry in France is a vital sector within the broader materials science field, contributing significantly to the economy and fostering innovation. This industry encom
Similar Deals
Bpifrance Amorçage Industriel, BNP Paribas Développement, private investors, banking partners → OSTREA
2025
Business Angels des Grandes Ecoles (BADGE) → AITHRA
2025
ONE CREATION Coopérative and MAIF → Ma Bonne Étoile
2023
Aquiti
invested in
Synboli
in 2024
in a Seed Stage deal
Disclosed details
Transaction Size: $4M